Patrickd Walsh News Today

Equities research analysts expect that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) will report $70.20 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for ANI Pharmaceuticals’ earnings, with the highest sales estimate coming in at $71.30 million and the lowest estimate coming in at $69.10 […]

Brokerages expect that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) will post earnings of $0.19 per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for ANI Pharmaceuticals’ earnings. The highest EPS estimate is $0.28 and the lowest is $0.10. ANI Pharmaceuticals posted earnings per share of $0.67 during […]

ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating) updated its FY 2022 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.34-$1.62 for the period, compared to the consensus earnings per share estimate of $1.15. The company issued revenue guidance of $295.00 million-$315.00 million, compared to the consensus revenue estimate of $292.77 million. Several […]

ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors - Dr. Tannenbaums successful track record in driving... | March 24, 2022

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) Director Patrick D. Walsh bought 5,000 shares of the business’s stock in a transaction dated Monday, March 21st. The shares were bought at an average cost of $27.76 per share, for a total transaction of $138,800.00. The acquisition was disclosed in a legal filing with the SEC, which […]

/PRNewswire/ -- Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announced today a $10 million investment to...

DURHAM, N.C., Jan. 27, 2022 /PRNewswire/ -- Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization (CDMO), announ...

/PRNewswire/ -- Alcami Corporation, a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO), announced today it has...

/PRNewswire/ -- Alcami Corporation, a leading pharmaceutical and biotech contract development and manufacturing organization (CDMO), announced today it has...

Press release content from PR Newswire. The AP news staff was not involved in its creation.